Inhibition of DNA restrictive endonucleases and Taq DNA polymerase by trimalonic acid C60

Chinese Science Bulletin

Volumn 52, Issue 13, 2007, Pages 1802-1806

  Yang, Xinlin ^a   Chen, Zhe ^a   Meng, Xianmei ^a   Li, Bo ^a   Tan, Xin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

DNA restrictive endonucleases; Inhibition; Reactive oxygen species; Taq DNA polymerase; Trimalonic acid C60 (TMA C60)

Indexed keywords

EID: 34547358721     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-007-0241-x     Document Type: Article

References (32)

1. Friedman S H, Decamp D L, Sijbesma R P, et al. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J Am Chem Soc, 1993, 115(15): 6506-6509
2. Sijbesma R, Srdanov G, Wudl F, et al. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J Am Chem Soc, 1993, 115(15): 6510-6512
3. Tokuyama H, Yamago S, Nakamura E, et al. Photoinduced biochemical activity of fullerene carboxylic acid. J Am Chem Soc, 1993, 115(17): 7918-7919
4. Bosi S, Ros T D, Spalluto G, et al. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem, 2003, 38(11-12): 913-923
5. Mashino T, Shimotohno K, Ikegami N, et al. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives. Bioorg Med Chem Lett, 2005, 15(4): 1107-1109
6. 60 with a defined three-dimensional structure. J Chem Soc Chem Commun, 1994, 1727-1728
7. Meng X M, Chen Z, Li B, et al. Inhibition of M-MuLV reverse transcriptase activity by fullerene derivatives. Chin Sci Bull, 2006, 51(20): 2550-2552
8. 60]fullerene complex. Bioconjug Chem, 2005, 16(5): 1058-1062
9. Toth E, Bolskar R D, Borel A, et al. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. J Am Chem Soc, 2005, 127(2): 799-805
10. 60) derivative with superoxide dismutase mimetic properties. Free Radical Bio Med, 2004, 37(8): 1191-1202
11. Mashino T, Nishikawa D, Takahashi K, et al. Antibacterial and antiproliferative activity of cationic fullerene derivatives. Bioorg Med Chem Lett, 2003, 13(24): 4395-4397
12. Rancan F, Rosan S, Boehm F, et al. Cytotoxicity and photocytotoxicity of a dendritic C(60) mono-adduct and a malonic acid C(60) tris-adduct on Jurkat cells. J Photochem Photobiol B, 2002, 67(3): 157-162
13. Yang X L, Fan C H, Zhu H S. Photo-induced cytotoxicity of malonic acid [C(60)]fullerene derivatives and its mechanism. Toxicol in Vitro, 2002, 16(1): 41-46
14. Dugan L L, Lovett E G, Quick K L, et al. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord, 2001, 7(3): 243-246
15. Wolff D J, Papoiu A D, Mialkowski K, et al. Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adducts. Arch Biochem Biophys, 2000, 378(2): 216-223
16. Cheng F Y, Yang X L, Zhu H S, et al. Synthesis of oligoadducts of malonic acid CM and their scavenging effects on hydroxyl radical. J Phys Chem Solid, 2000, 61(7): 1145-1148
17. Dugan L L, Turetsky, D M, Du C, et al. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci USA, 1997, 94(22): 9434-9439
18. 60, on nitric oxide-induced relaxation of rabbit aorta. Eur J Pharmacol, 1997, 327(2-3): 175-181
19. 60, on nitric oxide-induced relaxation of aortic smooth muscle. Gen Pharmacol, 1997, 29(3): 345-351
20. Lyon D Y, Adams L K, Falkner J C, et al. Antibacterial Activity of Fullerene Water Suspensions: effects of preparation method and particle size. Environ Sci Technol, 2006, 40(11): 4360-4366
21. 60 water suspension. Environ Toxicol Chem, 2005, 24(11): 2757-2762
22. Petkewich R. Buckyballs batter bacteria. Environ Sci Technol, 2005, 39(11):233A-234A
23. Mashino T, Usui N, Okuda K, et al. Respiratory chain inhibition by fullerene derivatives: hydrogen peroxide production caused by fullerene derivatives and a respiratory chain system. Bioorg Med Chem, 2003, 11(7): 1433-1438
24. Tsao N, Luh T, Chou C, et al. In vitro action of carboxyfullerene. Antimicrob Agents Chemother, 2002, 49(4): 641-649
25. Tsao N, Luh T, Chou C, et al. Inhibition of group A streptococcus infection by carboxyfullerene. Antimicrob Agents Chemother, 2001, 45(6): 1788-1793
26. Bosi S, Da Ros T, Castellano S, et al. Antimycobacterial activity of ionic fullerene derivatives. Bioorg Med Chem Lett, 2000, 10(10): 1043-1045
27. Mashino T, Okuda K, Hirota T, et al. Inhibition of E. coli growth by fullerene derivatives and inhibition mechanism. Bioorg Med Chem Lett, 1999, 9(20): 2959-2962
28. Tsao N, Kanakamma P P, Luh T, et al. Inhibition of Escherichia coli-induced meningitis by carboxyfullerence. Antimicrob Agents Chemother, 1999, 43(9): 2273-2277
29. Nermut M V, Hockley D J, Bron P, et al. Further evidence for hexagonal organization of HIV gag protein in prebudding assemblies and immature virus-like particles. J Struct Biol, 1998, 123(2): 143-149
30. 60 fullerene. Antimicrob Agents Chemother, 1993, 37(8): 1707-1710
31. Isakovic A, Markovic Z, Todorovic-Markovic B, et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci, 2006, 91(1): 173-183
32. 60 cytotoxicity is due to lipid peroxidation. Biomaterials, 2005, 26(36): 7587-7595